Sisram Medical (Sisram Medical) EBIT : $39.2 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Sisram Medical EBIT?

Sisram Medical's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was $17.4 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was $39.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sisram Medical's annualized ROC % for the quarter that ended in Dec. 2023 was 6.88%. Sisram Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 22.47%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sisram Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 19.70%.

Sisram Medical EBIT Historical Data

The historical data trend for Sisram Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sisram Medical EBIT Chart

Sisram Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

25.57

17.73

43.68

45.98

39.19

Sisram Medical Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial													22.62	24.10	21.88	21.76	17.43

Competitive Comparison of Sisram Medical's EBIT

For the Medical Devices subindustry, Sisram Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sisram Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sisram Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sisram Medical's EV-to-EBIT falls into.

Sisram Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $39.2 Mil.

Sisram Medical (OTCPK:SRAMF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sisram Medical's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	39.606 * ( 1 - 13.92% )	/	( (470.697	+	519.689)	/ 2 )
=	34.0928448	/	495.193
=	6.88 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	604.739	-	71.463	-	( 62.579	-	max(0, 92.553	-	249.645	+	62.579	))
=	470.697

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	613.502	-	23.212	-	( 70.601	-	max(0, 88.25	-	257.349	+	70.601	))
=	519.689

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Sisram Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	34.864	/	( ( (57.593 + max(82.934, 0))	+	(62.909 + max(106.938, 0)) )	/	2 )
=	34.864	/	( ( 140.527	+	169.847 )	/	2 )
=	34.864	/	155.187
=	22.47 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(83.846	+	84.091	+	2.8421709430404E-14)	-	(71.463	+	0	+	13.54)
=	82.934

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(83.456	+	80.55	+	22.044)	-	(23.212	+	0	+	55.9)
=	106.938

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sisram Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	39.194	/	198.955
	=	19.70 %

Sisram Medical EBIT Related Terms

Thank you for viewing the detailed overview of Sisram Medical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sisram Medical (Sisram Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sisram Medical Ltd (OTCPK:SRAMF) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

01696:Hong Kong

Address

HaHarash Street 18, Ofek Building 15, Industrial Park, Caesarea, ISR, 3079895

Website

https://www.sisram-medical.com

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Harmony, and ClearLift. It operates through the following geographical segments: Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa.

Sisram Medical (Sisram Medical) Headlines

No Headlines